Hasil Pencarian - Alan Burnett

  • Menampilkan 1 - 6 hasil dari 6
Perbaiki Hasil
  1. 1
    Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts

    Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts oleh Elisabeth Walsby, Val Walsh, Chris Pepper, Alan Burnett, Ken Mills

    Diterbitkan 2008-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    WTX is rarely mutated in acute myeloid leukemia

    WTX is rarely mutated in acute myeloid leukemia oleh Carolyn Owen, Priya Virappane, Mary Alikian, Irina Stasevich, Karin Summers, Debbie Lillington, Dominique Bonnet, Alan Burnett, Ken Mills, T. Andrew Lister, Jude Fitzgibbon

    Diterbitkan 2008-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Relationship between event-free survival and overall survival in acute myeloid leukemia: a report from SWOG, HOVON/SAKK, and MRC/NCRI

    Relationship between event-free survival and overall survival in acute myeloid leukemia: a report from SWOG, HOVON/SAKK, and MRC/NCRI oleh Megan Othus, Wim van Putten, Bob Lowenberg, Stephen H. Petersdorf, Sucha Nand, Harry Erba, Frederick Appelbaum, Robert Hills, Nigel Russell, Alan Burnett, Elihu Estey

    Diterbitkan 2016-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Defining the dose of gemtuzumab ozogamicin in combination with induction chemotherapy in acute myeloid leukemia: a comparison of 3 mg/m2 with 6 mg/m2 in the NCRI AML17 Trial

    Defining the dose of gemtuzumab ozogamicin in combination with induction chemotherapy in acute myeloid leukemia: a comparison of 3 mg/m2 with 6 mg/m2 in the NCRI AML17 Trial oleh Alan Burnett, Jamie Cavenagh, Nigel Russell, Robert Hills, Jonathan Kell, Gail Jones, Ove Juul Nielsen, Asim Khwaja, Ian Thomas, Richard Clark, on behalf of the UK NCRI AML Study Group

    Diterbitkan 2016-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    P503: A RANDOMISED TRIAL OF MOLECULAR MONITORING VERSUS STANDARD CLINICAL CARE IN YOUNGER ADULTS WITH ACUTE MYELOID LEUKAEMIA: RESULTS FROM THE UK NCRI AML17 AND AML19 STUDIES

    P503: A RANDOMISED TRIAL OF MOLECULAR MONITORING VERSUS STANDARD CLINICAL CARE IN YOUNGER ADULTS WITH ACUTE MYELOID LEUKAEMIA: RESULTS FROM THE UK NCRI AML17 AND AML19 STUDIES oleh Nicola Potter, Jelena Jovanovic, Adam Ivey, Abin Thomas, Charlotte Wilhelm-Benartzi, Amanda Gilkes, Ian Thomas, Sean Johnson, Joanna Canham, Steven Knapper, Asim Khwaja, Mary Frances Mcmullin, Jamie Cavenagh, Ulrik Malthe Overgaard, Richard Clark, Ellen Solomon, Sylvie Freeman, Robert Hills, Alan Burnett, Nigel Russell, Richard Dillon

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    The European LeukemiaNet: achievements and perspectives

    The European LeukemiaNet: achievements and perspectives oleh Rüdiger Hehlmann, David Grimwade, Bengt Simonsson, Jane Apperley, Michele Baccarani, Tiziano Barbui, Giovanni Barosi, Renato Bassan, Marie C. Béné, Ute Berger, Thomas Büchner, Alan Burnett, Nicolas C.P. Cross, Theo J.M. de Witte, Hartmut Döhner, Hervé Dombret, Hermann Einsele, Georg Engelich, Robin Foà, Christa Fonatsch, Nicola Gökbuget, Elaine Gluckman, Alois Gratwohl, Francois Guilhot, Claudia Haferlach, Thorsten Haferlach, Michael Hallek, Jörg Hasford, Andreas Hochhaus, Dieter Hoelzer, Jean-Jaques Kiladjian, Boris Labar, Per Ljungman, Ulrich Mansmann, Dietger Niederwieser, Gert Ossenkoppele, José M. Ribera, Harald Rieder, Hubert Serve, Petra Schrotz-King, Miguel A. Sanz, Susanne Saußele

    Diterbitkan 2011-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: